Microneedle mediated delivery of nanoparticles into human skin

International Journal of Pharmaceutics

Volumn 366, Issue 1-2, 2009, Pages 190-200

  Coulman, Sion A ^a   Anstey, Alexander ^b   Gateley, Chris ^b   Morrissey, Anthony ^c   McLoughlin, Peter ^d   Allender, Chris ^a   Birchall, James C ^a  

^a CARDIFF UNIVERSITY   (United Kingdom)

^b ROYAL GWENT HOSPITAL   (United Kingdom)

^c UNIVERSITY COLLEGE CORK   (Ireland)

^d Ireland   (Ireland)

Author keywords

Microneedle; Nanoparticles; Skin; Skin permeation; Transdermal; Vaccination

Indexed keywords

NANOPARTICLE;

ARTICLE; COLLOID; CONTROLLED STUDY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN; HUMAN TISSUE; HYDRODYNAMICS; MICRONEEDLE; NEEDLE; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; SKIN PENETRATION; SURFACE PROPERTY; ZETA POTENTIAL;

AGED; DIFFUSION; FEMALE; FLUORESCENCE; HUMANS; MICROINJECTIONS; NANOPARTICLES; NEEDLES; PERMEABILITY; PHARMACEUTICAL PREPARATIONS; SKIN; SKIN ABSORPTION;

EID: 57849157314     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2008.08.040     Document Type: Article

References (76)

1. Alvarez-Roman R., Naik A., Kalia Y.N., Guy R.H., and Fessi H. Skin penetration and distribution of polymeric nanoparticles. J. Control. Release 99 (2004) 53-62
2. Apel P. Track etching technique in membrane technology (invited talk). Radiat. Meas. 34 (2001) 559-566
3. Banks S.L., Pinninti R.R., Gill H.S., Crooks P.A., Prausnitz M.R., and Stinchcomb A.L. Flux across of microneedle-treated skin is increased by increasing charge of Naltrexone and Naltrexol in vitro. Pharm. Res. 25 (2008) 1677-1685
4. Baroli B., Ennas M.G., Loffredo F., Isola M., Pinna R., and Lopez-Quintela M.A. Penetration of metallic nanoparticles in human full-thickness skin. J. Invest. Dermatol. 127 (2007) 1701-1712
5. Barry B.W. Review: novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 14 (2001) 101-114
6. Barry B.W. Drug delivery routes in skin: a novel approach. Adv. Drug Del. Rev. 54 (2002) S31-S40
7. Barry M.E., Pinto-Gonzalez D., Orson F.M., Mckenzie G.J., Petry G.R., and Barry M.A. Role of endogenous endonucleases and tissue site in transfection and CpG-mediated immune activation after naked DNA injection. Hum. Gene Ther. 10 (1999) 2461-2480
8. Birchall J.C., Coulman S., Pearton M., Allender C., Brain K., Anstey A., Gateley C., Wilke N., and Morrissey A. Cutaneous DNA delivery and gene expression in ex vivo human skin explants via wet-etch microfabricated microneedles. J. Drug Target 13 (2005) 415-421
9. Bos J.D., and Meinardi M.M.H.M. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp. Dermatol. 9 (2000) 165-169
10. Brendler E., Ratkje S.K., and Hertz H.G. Streaming potentials of nuclepore membranes by the electric wok method. Electrochim. Acta 41 (1995) 169169-169176
11. Burnette R.R., and Ongpipattanakul B. Characterization of the permselective properties of excised human skin during iontophoresis. J. Pharm. Sci. 76 (1987) 765-773
12. Campbell R.B. Tumor physiology and delivery of nanopharmaceuticals. Anti Cancer Agents Med. Chem. 6 (2006) 503-512
13. Chiarello K. Breaking the barrier: advances in transdermal technology. Pharm. Technol. 28 (2004) 46-56
14. Christophers E., and Kligman A. Preparation of isolated sheets of human stratum corneum. Arch. Dermatol. 88 (1963) 702-704
15. Combadiere B., and Mahe B. Particle-based vaccines for transcutaneous vaccination. Comp. Immunol. Microbiol. Infect. Dis. 31 (2008) 293-315
16. Cormier M., Johnson B., Ameri M., Nyam K., Libiran L., Zhang D.D., and Daddona P. Transdermal delivery of desmopressin using a coated microneedle array patch system. J. Control. Release 97 (2004) 503-511
17. Coulman S.A., Allender C., and Birchall J.C. Microneedles and other physical methods for overcoming the stratum corneum barrier for cutaneous gene therapy. Crit. Rev. Ther. Drug Carrier Syst. 23 (2006) 205-258
18. Coulman S.A., Barrow D., Anstey A., Gateley C., Morrissey A., Wilke N., Allender C., Brain K., and Birchall J.C. Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles. Curr. Drug Deliv. 3 (2006) 65-75
19. Cross S.E., and Roberts M.S. Physical enhancement of transdermal drug application: is delivery technology keeping up with pharmaceutical development. Curr. Drug Deliv. 1 (2004) 81-92
20. 2 aqueous solutions. J. Colloid Interf. Sci. 132 (1989) 27-33
21. Elias P.M. Epidermal lipids, barrier function, and desquamation. J. Invest. Dermatol. 80 (1983) 44s-49s
22. Elias P.M. Stratum corneum defensive functions: an integrated view. J. Invest. Dermatol. 125 (2005) 183-200
23. Florence A.T. Pharmaceutical nanotechnology: more than size: ten topics for research. Int. J. Pharm. 339 (2007) 1-2
24. Frerichs D.M., Ellingsworth L.R., Frech S.A., Flyer D.C., Villar C.P., Yu J.M., and Glenn G.M. Controlled, single-step, stratum corneum disruption as a pretreatment for immunization via a patch. Vaccine 26 (2008) 2782-2787
25. Gadiraju P.D., Park J.H., Lee J.W., Prausnitz M.R., and Allen M.G. Micro-ablation of skin by arc-discharge jet ejection for transdermal drug delivery. Transducers '07 & Eurosensors, vol. XXI (2007) U982-U983
26. Giudice E.L., and Campbell J.D. Needle-free vaccine delivery. Adv. Drug Deliv. Rev. 58 (2006) 68-89
27. Glenn G.M., and Kenney R.T. Mass vaccination: solutions in the skin. In: Plotkin S.A. (Ed). Mass Vaccination: Global Aspects-Progress and Obstacles (2006), Springer, New York 247-268
28. Gonzalez E.G., Speaker T.J., Leake D., Contag C.H., and Kaspar R.L. In vivo delivery of functional macromolecules including siRNAs to skin by novel soluble-tip microneedle arrays. J. Invest. Dermatol. 128 (2008) S130-S1130
29. Haq M.I., Smith E., John D.N., Kalavala M., Edwards C., Anstey A., Morrissey A., and Birchall J.C. Clinical administration of microneedles: skin puncture, pain and sensation. Biomed. Microdevices (2008) [Epub ahead of print]
30. Henry S., Mcallister D.V., Allen M., and Prausnitz M.R. Microfabricated microneedles: a novel approach to transdermal drug delivery. J. Pharm. Sci. 87 (1998) 922-925
31. Hirschberg H., De Wijdeven G., Kelder A.B., Van Den Dobbelsteen G., and Kerstena G.F.A. Bioneedles (TM) as vaccine carriers. Vaccine 26 (2008) 2389-2397
32. Hoet P., Bruske-Hohlfeld I., and Salata O. Nanoparticles-known and unknown health risks. J. Nanobiotechnol. 2 (2004) 12
33. Huismann I.H., Pradanos P., Calvo J.I., and Hernandez A. Electroviscous effects, streaming potential and zeta potential in polycarbonate track-etched membranes. J. Membr. Sci. 178 (2000) 79-92
34. Keesom W.H., Zelenka R.L., and Radke C.J. A zeta-potential model for ionic surfactant adsorption on an ionogenic hydrophobic surface. J. Colloid Interf. Sci. 125 (1988) 575-585
35. Kenney R.T., Frech S.A., Muenz L.R., Villar C.P., and Glenn G.M. Dose sparing with intradermal injection of influenza vaccine. N. Engl. J. Med. 351 (2004) 2295-2301
36. Kohli A.K., and Alpar H.O. Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge. Int. J. Pharm. 275 (2004) 13-17
37. Kuntsche J., Bunjes H., Fahr A., Pappinen S., Rönkkö S., Suhonen M., and Urtti A. Interaction of lipid nanoparticles with human epidermis and an organotypic cell culture model. Int. J. Pharm. 354 (2008) 180-195
38. La Montagne J.R., and Fauci A.S. Effect of intradermal influenza vaccination-can less be more?. N. Engl. J. Med. 351 (2004) 2330-2332
39. Lademann J., Weigmann H.J., Rickmeyer C., Barthelmes H., Schaefer H., Mueller G., and Sterry W. Penetration of titanium dioxide microparticles in a sunscreen formulation into the Horny Layer and the follicular orifice. Skin Pharmacol. Physiol. 12 (1999) 247-256
40. Lademann J., Richter H., Teichmann A., Otberg N., Blume-Peytavi U., Luengo J., Weiss B., Schaefer U.F., Lehr C.M., Wepf R., and Sterry W. Nanoparticles-an efficient carrier for drug delivery into the hair follicles. Eur. J. Pharm. Biopharm. 66 (2007) 159-164
41. Lawson L.B., Freytag L.C., and Clements J.D. Use of nanocarriers for transdermal vaccine delivery. Clin. Pharmacol. Ther. 82 (2007) 641-643
42. Lee P.W., Peng S.F., Su C.J., Mi F.L., Chen H.L., Wei M.C., Lin H.J., and Sung H.W. The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery. Biomaterials 29 (2008) 742-751
43. Liu Y., Costigan G., and Bellhouse B.J. Performance studies of a conical nozzle designed for the macromolecular skin delivery. J. Drug. Target 16 (2008) 206-212
44. Manolova V., Flace A., Bauer M., Schwarz K., Saudan P., and Bachmann M.F. Nanoparticles target distinct dendritic cell populations according to their size. Eur. J. Immunol. 38 (2008) 1404-1413
45. Martanto W., Davis S.P., Holiday N.R., Wang J., Gill H.S., and Prausnitz M.R. Transdermal delivery of insulin using microneedles in vivo. Pharm. Res. 21 (2004) 947-952
46. Solid and hollow microneedles for transdermal protein delivery. In: Mcallister D.V., Kaushik S., Patel P.N., Mayberry J.L., Allen M.G., and Prausnitz M.R.D.V.M. (Eds). Proc. Int. Symp. Control Release. Bioact. Mater., vol. 26. Controlled Release Society, Boston (1999) 192-193
47. Mcallister D.V., Allen M.G., and Prausnitz M.R. Microfabricated microneedles for gene and drug delivery. Annu. Rev. Biomed. Eng. 2 (2000) 289-313
48. Mcallister D.V., Wang P.M., Davis S.P., Park J.H., Canatella P.J., Allen M.G., and Prausnitz M.R. Microfabricated Needles for Transdermal Delivery of Macromolecules and Nanoparticles: Fabrication Methods and Transport Studies 100 (2003), PNAS, USA pp. 13755-13760
49. Mikszta J.A., Alarcon J.B., Brittingham J.M., Sutter D.E., Pettis R.J., and Harvey N.G. Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery. Nat. Med. 8 (2002) 415-419
50. Mikszta J.A., Sullivan V.J., Dean C., Waterston A.M., Alarcon J.B., Dekker J.P., Brittingham J.M., Huang J., Hwang C.R., Ferriter M., Jiang G., Mar K., Saikh K.U., Stiles B.G., Roy C.J., Ulrich R.G., and Harvey N.G. Protective immunization against inhalational anthrax: a comparison of minimally invasive delivery platforms. J. Infect. Dis. 191 (2005) 278-288
51. Mitragotri S. Breaking the skin barrier. Adv. Drug Deliv. Rev. 56 (2004) 555-556
52. Modamio P., Lastra C.F., and Marino E.L. A comparative in vitro study of percutaneous penetration of [beta]-blockers in human skin. Int. J. Pharm. 194 (2000) 249-259
53. Nasseri B., and Florence A.T. The relative flow of the walls of phospholipid tether bilayers. Int. J. Pharm. 298 (2005) 372-377
54. Papazoglou E.S., Babu S., Fan C., Sunkari C., and Uitto J. Particle size and bilayer rigidity effects on skin diffusion of nanosomes. J. Invest. Dermatol. 128 (2008) S54
55. Pearton M., Allender C., Brain K., Anstey A., Gateley C., Wilke N., Morrissey A., and Birchall J. Gene delivery to the epidermal cells of human skin explants using microfabricated microneedles and hydrogel formulations. Pharm. Res. 25 (2008) 407-416
56. Prausnitz M.R. Microneedles for transdermal drug delivery. Adv. Drug Deliv. Rev. 56 (2004) 581-587
57. Prausnitz M.R., Mitragotri S., and Langer R. Current status and future potential of transdermal drug delivery. Nat. Rev. Drug Discov. 3 (2004) 115-124
58. Rama Rao P., Reddy M.N., Ramakrishna S., and Diwan P.V. Comparative in vivo evaluation of propranolol hydrochloride after oral and transdermal administration in rabbits. Eur. J. Pharm. Biopharm. 56 (2003) 81-85
59. Roxhed N., Samel B., Nordquist L., Griss P., and Stemme G. Painless drug delivery through microneedle-based transdermal patches featuring active infusion. IEEE Trans. Biomed. Eng. 55 (2008) 1063-1071
60. Ruenraroengsak P., and Florence A.T. The diffusion of latex nanospheres and the effective (microscopic) viscosity of HPMC gels. Int. J. Pharm. 298 (2005) 361-366
61. Ruponen M., Honkakoski P., Ronkko S., Pelkonen J., Tammi M., and Urtti A. Extracellular and intracellular barriers in non-viral gene delivery. J. Control. Release 93 (2003) 213-217
62. Salata O.V. Applications of nanoparticles in biology and medicine. J. Nanobiotechnol. 2 (2004) 3
63. Sanna V., Gavini E., Cossu M., Rassu G., and Giunchedi P. Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. J. Pharm. Pharmacol. 8 (2007) 1057-1064
64. Scheulplein R.L., and Blank I.H. Permeability of the skin. Physiol. Rev. 51 (1971) 702-747
65. Schuetz Y.B., Naik A., Guy R.H., and Kalia Y.N. Emerging strategies for the transdermal delivery of peptide and protein drugs. Expert Opin. Drug Deliv. 2 (2005) 533-548
66. Sheiheta L., Chandra P., Batheja P., Devore D., Kohn J., and Michniak B. Tyrosine-derived nanospheres for enhanced topical skin penetration. Int. J. Pharm. 350 (2008) 312-319
67. Smart W.H., and Subramanian K. The use of silicon microfabrication technology in painless blood glucose monitoring. Diabetes Technol. Ther. 2 (2000) 549-559
68. Stott P.W., Williams A.C., and Barry B.W. Mechanistic study into the enhanced transdermal permeation of a model [beta]-blocker, propranolol, by fatty acids: a melting point depression effect. Int. J. Pharm. 219 (2001) 161-176
69. Sugrue S. Predicting and controlling colloid suspension stability using electrophoretic mobility and particle size measurements. Am. Lab. 24 (1992) 64-71
70. Ting W.W., Vest C.D., and Sontheimer R.D. Review of traditional and novel modalities that enhance the permeability of local therapeutics across the stratum corneum. Int. J. Dermatol. 43 (2004) 538-547
71. Toll R., Jacobi U., Richter H., Lademann J., Schaefer H., and Blume-Peytavi U. Penetration profile of microspheres in follicular targeting of terminal hair follicles. J. Invest. Dermatol. 123 (2003) 168-176
72. Wertz P.W., and Van Den Bergh. Review. The physical, chemical and functional properties of lipids in the skin and other biological barriers. Chem. Phys. Lipids 91 (1998) 85-96
73. Widera G., Johnson J., Kim L., Libiran L., Nyam K., Daddona P.E., and Cormier M. Effect of delivery parameters on immunization to ovalbumin following intracutaneous administration by a coated microneedle array patch system. Vaccine 24 (2006) 1653-1664
74. Wilke N., Mulcahy A., Ye S.-R., and Morrissey A. Process optimization and characterization of silicon microneedles fabricated by wet etch technology. Microelectron. J. 36 (2005) 650-656
75. Zhang L.W., and Monteiro-Riviere N.A. Assessment of quantum dot penetration into intact, tape-stripped. Abraded and flexed rat skin. Skin Pharmacol. Physiol. 21 (2008) 166-180
76. Zhang L.W., Yu W.W., Colvin V.L., and Monteiro-Riviere N.A. Biological interactions of quantum dot nanoparticles in skin and in human epidermal keratinocytes. Toxicol. Appl. Pharmacol. 228 (2008) 200-211